FaStep : IgG/IgM Antibody Rapid Test Kit
FaStep : IgG/IgM Antibody Rapid Test Kit
FaStep : IgG/IgM Antibody Rapid Test Kit
FaStep : IgG/IgM Antibody Rapid Test Kit

FaStep : IgG/IgM Antibody Rapid Test Kit (FDA/EUA)

Regular price $325.00
Sale price $325.00 Regular price $350.00
Unit price
Save 7%
In Stock
Choose your purchase type:

Subscription Details:

  • Save 10% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Same-day shipping on all orders. Free over $250.

  • Save 10% on auto-renew orders.  Learn more
  • Interested in our wholesale program?  Join now
FaStep COVID-19 IgG/IgM Antibody Rapid Test Device by Azure Biotech is an in-vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum or plasma. FaStep is authorized for use with fingerstick whole blood specimen at the point-of-care. FaStep has been validated by the FDA and found to have a 100% Sensitivity for IgM (30/30) and 98.8% Specificity for IgM (79/80). IgG Sensitivity was 90% (27/30) and Specificity was 100% (80/80).
  • What's in the Box: 20 IgG/IgM Rapid Antibody Tests Cassette, 20 Sterile Fingerstick Lancets, 20 Sterile Alcohol Pads, 20 Droppers for Blood Collection, 20 Vials with Buffer
  • This test has been authorized by the FDA under a EUA for use by authorized laboratories. It is a point-of-care test for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples.
  • This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
  • Read the complete Quick Reference Instructions before performing the test.
  • There should be a blue line in the control region (next to “C”) before testing, discard the device if there is no blue line.
  • Due to the risk of false-positive results, confirmation of positive results should be considered using second, different IgG or IgM assay.